Author

Łukasz Grabowski

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Antibacterial activity of a newly identified phage-derived endolysin and its parental bacteriophage against clinical uropathogenic Escherichia coli

The increasing prevalence of antibiotic-resistant uropathogenic Escherichia coli highlights the need for antibacterial strategies that can complement or extend beyond conventional antibiotic treatment. Bacteriophages and phage-derived lytic enzymes represent promising alternatives because of their distinct mechanisms o...

Wojciech Wesołowski, Sylwia Bloch, Grzegorz Czerwonka et al. · bioRxiv · 0 citations

Open access Sep 2026

Molecular-networking-based characterization of cytotoxic metabolites produced by the cyanobacterium Nostoc edaphicum CCNP1411.

Cyanobacteria of the genus Nostoc, known for their large genomes and rich repertoire of biosynthetic gene clusters, represent a prolific source of structurally diverse secondary metabolites with diverse biological activities, including cytotoxic effects. However, the identification of bioactive compounds is often hinde...

R. Konkel, Marta Cegłowska, Łukasz Grabowski et al. · Molecular diversity · 0 citations

Open access Jul 2026

Significant variability in virulence factors and antibiotic resistance of uropathogenic Escherichia coli strains may be counteracted by their susceptibility to lytic bacteriophages

This multi-faceted approach provides a strong foundation for the development of precision phage therapy against multidrug-resistant UPEC infections and highlights the substantial potential of carefully selected bacteriophages as effective and precise antimicrobial tools.

Wojciech Wesołowski, Grzegorz Czerwonka, Katarzyna Zegadło et al. · Scientific Reports · 0 citations